Hepatotoxicity induced by acute and chronic paracetamol overdose in children: Where do we stand?

Hoi Yan Tong1, Nicolás Medrano1, Alberto Manuel Borobia1

  • 1Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.

Insights

Chronic paracetamol poisoning poses a significant risk for pediatric hepatotoxicity and acute liver failure. Delayed medical attention in these cases is a critical factor, necessitating increased clinical suspicion.

Area of Science:

  • Pediatric Toxicology
  • Hepatology
  • Emergency Medicine

Background:

  • Limited data exist on hepatotoxicity from acute or chronic paracetamol poisoning in children.
  • Existing paracetamol poisoning management guidelines may have weaknesses.

Purpose of the Study:

  • To investigate the incidence and characteristics of paracetamol poisoning in pediatric patients.
  • To assess the risk of hepatotoxicity and acute liver failure associated with acute versus chronic paracetamol poisoning in children.

Main Methods:

  • Retrospective study of pediatric patients (<18 years) with measurable paracetamol levels.
  • Data collected from emergency department visits for suspected paracetamol overdose between 2005 and 2010.
  • Analysis of poisoning causes, time to medical care, and incidence of hepatotoxicity.

Main Results:

  • Ninety-two pediatric cases of suspected paracetamol poisoning were identified.
  • Chronic poisoning cases showed a higher frequency of hepatotoxicity (7/8) and acute liver failure (3/8) compared to acute poisoning (1/49).
  • Average time to medical care was significantly longer for chronic poisoning (52.3 hours) than acute poisoning (6.83 hours).

Conclusions:

  • Chronic paracetamol poisoning is a significant risk factor for hepatotoxicity and acute liver failure in children.
  • Delayed medical intervention may contribute to adverse outcomes.
  • Clinicians require a heightened clinical suspicion for chronic paracetamol poisoning in pediatric patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
102
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
844
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
131